Skip to main content
Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News FAQ
On This Report

Nonmydriatic Fundus Cameras Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 12283| Published Date: Aug-2026| Format: PDF, Excel
Market Outlook

Market Size and Growth Outlook

Nonmydriatic Fundus Cameras Market size was estimated at USD 204.9 million in 2026 and is projected to grow at a 5.61% CAGR from 2027 to 2036, attaining USD 353.67 million by 2036. The industry revenue for 2027 is calculated at USD 214.57 million.

Base Year Value (2026)
USD 204.9 million
CAGR (2027-2036)
5.61%
Forecast Year Value (2036)
USD 353.67 million
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Nonmydriatic Fundus Cameras Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads with 39.64% share, driven by routine retinal imaging adoption, integrated diabetic retinopathy screening workflows, and strong access to advanced diagnostic equipment across clinical settings.
  • Asia Pacific is growing at a 6.78% CAGR due to rising demand for high-volume, efficient eye screening and wider adoption of fast, non-dilated retinal imaging in resource-constrained care settings.

Segment Momentum

  • Tabletop systems held a 53.55% market share in 2026 due to their routine use in structured clinical settings, where stable image capture, consistent workflows, and dependable retinal imaging support everyday diagnostic practice.
  • Ophthalmic & optometrist offices are the fastest-growing end-use segment as retinal imaging becomes part of routine consultations, enabling earlier screening and more efficient in-office patient assessment.

Market Expansion Drivers

  • Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies.
  • Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency.
  • Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations.

Leading Market Participants

  • Major players in the nonmydriatic fundus cameras market include Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Canon Medical Systems Corporation (Japan), NIDEK Co., Ltd. (Japan), Kowa Company, Ltd. (Japan), Optomed Plc (Finland), Haag-Streit AG (Switzerland), Optos plc (United Kingdom).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 204.9 million
  • 2027 Estimated Market Size: USD 214.57 million.
  • Projected Market Size: USD 353.67 million by 2036
  • Growth Forecast: 5.61% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Tabletop (Type) | Hospitals (End-use)
  • Emerging Opportunity Segment: Handheld (Type) | Ophthalmic & Optometrist Offices (End-use)
Market Dynamics

Market Growth Drivers and Industry Trends

Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies

The rising incidence of diabetic retinopathy and glaucoma will drive the nonmydriatic fundus cameras market growth by increasing the need for routine retinal examination and early detection of vision-threatening conditions. Growing diabetic and aging populations are contributing to a larger pool of patients requiring periodic monitoring of retinal health, while glaucoma often progresses without noticeable symptoms during its early stages. Nonmydriatic fundus cameras enable rapid capture of retinal images without pharmacological pupil dilation, making screening more convenient across ophthalmology clinics, diabetic care centers, and primary healthcare settings. Their ability to document retinal changes and support repeat examinations also facilitates ongoing disease monitoring, particularly for patients requiring regular assessment of disease progression.

Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency

Advancements in high-resolution ophthalmic imaging are strengthening the nonmydriatic fundus cameras market by enabling clearer visualization of subtle retinal abnormalities and improving the consistency of image-based examinations. Enhanced image resolution, improved sensors, automated image capture, and better image-processing capabilities can assist clinicians in identifying lesions, vascular changes, hemorrhages, and other retinal abnormalities with greater clarity. Integration with digital ophthalmology workflows further allows images to be stored, reviewed, shared, and incorporated into patient records, reducing manual handling during examinations. These capabilities are particularly valuable in busy eye-care environments where efficient imaging and reliable documentation are important for screening and follow-up assessments.

Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations

The expansion of preventive eye care initiatives will propel nonmydriatic fundus cameras market demand as healthcare providers increasingly emphasize early identification of retinal disorders before substantial vision loss occurs. Community screening campaigns, diabetes management programs, occupational health initiatives, and primary-care-based eye assessments can benefit from examination methods that are rapid, noninvasive, and comparatively simple to deploy. Because retinal imaging can be performed without routine dilation, healthcare personnel can conduct examinations with less disruption to patients and clinical workflows. Wider incorporation of retinal screening into preventive care pathways can therefore increase the use of compact and digitally connected imaging systems across settings beyond conventional ophthalmology practices.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising prevalence of diabetic retinopathy and glaucoma increasing demand for retinal screening technologies 2.00% High North America, Asia Pacific High Near Term
Advancements in high-resolution ophthalmic imaging improving diagnostic accuracy and workflow efficiency 1.70% Moderate Europe, North America Medium Mid Term
Expanding preventive eye care programs boosting adoption of rapid noninvasive retinal examinations 1.40% High Asia Pacific, Latin America Medium Mid Term
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Regional Forecast

Regional Demand Dynamics

Nonmydriatic Fundus Cameras Market
Largest Region
North America
39.64% Market Share in 2026

North America (Largest Region)

North America held the largest share of the nonmydriatic fundus cameras market, accounting for 39.64% in 2026. The region’s strong position is supported by advanced ophthalmic care infrastructure, growing demand for efficient retinal screening, and increasing adoption of digital diagnostic technologies. Greater emphasis on early detection of diabetic eye disease and other retinal disorders, along with the integration of imaging systems into specialized and primary care settings, is encouraging broader use of nonmydriatic cameras.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is poised for the fastest growth as healthcare infrastructure expands and access to ophthalmic diagnostics improves across both developed and emerging markets. Rising awareness of preventable vision loss, growing screening needs associated with chronic diseases, and increasing investment in digital healthcare are creating favorable conditions for retinal imaging adoption. Portable and user-friendly camera systems are also helping extend screening capabilities to community and outpatient settings where conventional ophthalmic equipment may be less accessible.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
Country Insights

Key Country Insights

Germany 🇩🇪

Clinical Imaging Precision

Germany emphasizes high-accuracy nonmydriatic fundus cameras that integrate with ophthalmology and hospital imaging systems. Medical facilities in Germany continue investing in dependable diagnostic equipment that enhances workflow efficiency while supporting standardized eye disease screening.

France 🇫🇷

Community Screening Support

France promotes nonmydriatic fundus cameras for accessible retinal screening across hospitals and community healthcare facilities. Medical providers in France prioritize user-friendly imaging systems that improve diagnostic consistency while supporting preventive ophthalmic care programs.

Italy 🇮🇹

Outpatient Imaging Expansion

Italy emphasizes practical nonmydriatic fundus camera deployment in ophthalmology clinics and outpatient diagnostic centers. Healthcare providers in Italy continue adopting versatile imaging systems that simplify retinal examinations while improving clinical workflow efficiency.

Japan 🇯🇵

Preventive Vision Care

Japan focuses on nonmydriatic fundus cameras for preventive eye examinations and routine health screening. Healthcare institutions in Japan continue expanding compact, high-resolution imaging solutions that improve diagnostic efficiency while addressing the needs of an aging population.

South Korea 🇰🇷

Smart Imaging Integration

South Korea supports nonmydriatic fundus camera adoption through digital healthcare initiatives and advanced ophthalmic diagnostics. Providers in South Korea increasingly integrate imaging platforms with AI-assisted analysis to streamline retinal assessments and improve patient management.

United States 🇺🇸

Digital Eye Diagnostics

The U.S. nonmydriatic fundus cameras market prioritizes efficient retinal imaging across hospitals, clinics, and primary care settings. Healthcare providers in the U.S. increasingly adopt AI-compatible imaging systems that improve screening workflows and support earlier detection of retinal diseases.

Segment Analysis

Segment Leadership and Growth Trends

Nonmydriatic Fundus Cameras Market Share (%), by Type, 2026

Tabletop
Handheld

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Type Segment Analysis: Tabletop (Largest Segment) vs Handheld (Fastest-Growing Segment)

Tabletop systems dominated the nonmydriatic fundus cameras market, accounting for a 53.55% share in 2026. Their leading position is supported by their established use in ophthalmic facilities where imaging systems are integrated into routine examination workflows. Tabletop cameras generally provide stable positioning, consistent image acquisition, and features suited to detailed retinal examinations, making them valuable for clinical environments that conduct regular eye screening and diagnostic procedures. Their compatibility with established ophthalmic infrastructure and suitability for repeated examinations further supports adoption among healthcare providers. As the need for retinal imaging increases for the assessment and monitoring of ocular and systemic conditions, tabletop systems continue to serve as a dependable imaging platform.

Handheld fundus cameras are expected to register the fastest growth as eye-care providers increasingly seek portable imaging solutions that can be used across a broader range of patient-care environments. Their compact design allows retinal imaging to be performed outside conventional ophthalmic examination rooms, supporting screening in primary care, outreach programs, bedside settings, and other locations where mobility is important. Handheld systems can also improve accessibility for patients who may have difficulty visiting specialized ophthalmology facilities. The increasing emphasis on decentralized eye screening and early identification of retinal abnormalities is creating favorable conditions for wider adoption of portable fundus imaging technologies.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ophthalmic & Optometrist Offices (Fastest-Growing Segment)

Hospitals accounted for the largest share of the nonmydriatic fundus cameras market, representing 47.49% in 2026. Hospitals have a strong need for retinal imaging equipment because ophthalmic evaluation can form part of both specialized eye-care services and broader diagnostic workflows. Fundus cameras are useful for documenting retinal conditions, monitoring disease progression, and supporting clinical assessments, particularly in settings with access to multidisciplinary healthcare teams. The presence of established diagnostic infrastructure and the ability to integrate imaging into comprehensive patient-care pathways further support hospital adoption. Growing attention to early detection of retinal abnormalities is reinforcing the role of fundus imaging within hospital-based care.

Ophthalmic & optometrist offices are positioned as the fastest-growing end-use segment as eye-care services increasingly emphasize accessible and efficient diagnostic screening. Office-based practitioners can use nonmydriatic fundus cameras to capture retinal images during routine examinations without relying on more specialized hospital infrastructure. The technology can support earlier identification of abnormalities and improve documentation for follow-up assessments, making it valuable in outpatient eye-care workflows. Increasing demand for convenient eye examinations and the broader integration of digital imaging into routine optometric and ophthalmic practice are supporting stronger adoption across these offices.

Segment Sub-Segment Largest Segment Fastest Growing
Type Tabletop, Handheld Tabletop Handheld
End-use Hospitals, Ophthalmology Clinics, Ophthalmic & Optometrist Offices Hospitals Ophthalmic & Optometrist Offices
Read our Research Approach →
Competitive Landscape

Competitive Landscape and Market Positioning

Prominent players in the nonmydriatic fundus cameras market:

1. Carl Zeiss Meditec AG (Germany)

2. Topcon Corporation (Japan)

3. Canon Medical Systems Corporation (Japan)

4. NIDEK Co. Ltd. (Japan)

5. Kowa Company Ltd. (Japan)

6. Optomed Plc (Finland)

7. Haag-Streit AG (Switzerland)

8. Optos plc (United Kingdom)

The nonmydriatic fundus cameras market is progressing through enhanced imaging clarity and diagnostic efficiency innovations. Continuous R&D is enabling more accurate and patient-friendly ophthalmic solutions. The market is also witnessing frequent upgrades aligned with clinical imaging needs.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Carl Zeiss Meditec AG (Germany)
Topcon Corporation (Japan)
Canon Medical Systems Corporation (Japan)
NIDEK Co. Ltd. (Japan)
Kowa Company Ltd. (Japan)
Optomed Plc (Finland)
Haag-Streit AG (Switzerland)
Optos plc (United Kingdom).
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Topcon Healthcare, Inc. Jul-24 Topcon Healthcare appointed Lance Patton as Chief Commercial Officer to lead its transition toward a direct sales and service model. The role focuses on commercial restructuring, integration of AI-enabled disease detection solutions, and development of customized ophthalmic imaging offerings to strengthen market positioning in diagnostic eye care solutions.
Optomed May-24 Optomed launched the Aurora AEYE handheld fundus camera integrated with artificial intelligence capabilities for rapid detection of mild diabetic retinopathy. The device enables point-of-care retinal screening in primary care settings, supporting early disease identification and expanding access to nonmydriatic ophthalmic imaging in decentralized healthcare environments.
NIDEK CO., LTD.; Orbis International Jan-24 NIDEK CO., LTD. and Orbis International partnered to enhance AI-based eye screening programs in Vietnam through the deployment of donated fundus cameras. The collaboration supports diabetic retinopathy screening initiatives and strengthens the integration of artificial intelligence into ophthalmic diagnostics across emerging healthcare markets.
Carl Zeiss Meditec AG Dec-23 Carl Zeiss Meditec AG acquired the Dutch Ophthalmic Research Center to expand its ophthalmic portfolio and digitally enabled workflow solutions. The acquisition strengthens its position in advanced eye care technologies by broadening its diagnostic imaging capabilities and enhancing its integrated ophthalmology solutions across multiple eye disease applications.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Nonmydriatic Fundus Cameras Market — Custom Segments

Segment Sub-Segment
AI Integration Level Non-AI Imaging, AI-Assisted Screening, AI-Based Automated Screening
Connectivity Architecture Standalone, Network-Connected, Cloud-Connected
Purchasing Model Capital Equipment Purchase, Leasing, Managed Equipment & Service Contracts

Nonmydriatic Fundus Cameras Market — Custom TOC

Custom Chapter Custom Details
AI-Enabled Retinal Diagnostics Landscape
  • AI-Assisted Image Analysis Technologies
  • Clinical Decision Support Integration
  • Automated Disease Detection Trends
  • Diagnostic Accuracy and Workflow Enhancement
  • Future AI Innovation Outlook
Teleophthalmology Opportunity Mapping
  • Remote Eye Screening Models
  • Virtual Care Integration
  • Rural and Underserved Healthcare Access
  • Connected Diagnostic Ecosystems
  • Commercial Expansion Opportunities
  • Future Teleophthalmology Adoption
Ophthalmic Screening Adoption Analysis
  • Preventive Eye Screening Trends
  • Early Disease Detection Initiatives
  • Screening Adoption Across Care Settings
  • Healthcare Provider Adoption Drivers

Need a different cut of the data?

Request Custom Research
Frequently Asked Questions

How much revenue does the nonmydriatic fundus cameras market generate?

The market size of the nonmydriatic fundus cameras is estimated at USD 214.57 million in 2027.

What is the forecasted size of the nonmydriatic fundus cameras industry?

Nonmydriatic Fundus Cameras Market size was estimated at USD 204.9 million in 2026 and is projected to grow at a 5.61% CAGR from 2027 to 2036, attaining USD 353.67 million by 2036.

How is the rising burden of diabetic retinopathy and glaucoma reshaping retinal screening adoption across frontline care settings?

Increasing disease prevalence is driving earlier and more routine screening in clinics and diabetes centers, pushing adoption of nonmydriatic systems that enable high-throughput imaging without dilation while supporting faster referral and follow-up decisions in constrained outpatient workflows.

Why are preventive eye care programs becoming a key demand driver for nonmydriatic fundus camera deployment?

Preventive programs are expanding population-level screening needs, favoring quick, noninvasive retinal exams. This is increasing investment in scalable imaging systems that support rapid assessments, efficient triage, and broad access outside specialized ophthalmology environments.

Why do tabletop nonmydriatic fundus cameras lead the market?

Tabletop systems held a 53.55% market share in 2026 due to their routine use in structured clinical settings, where stable image capture, consistent workflows, and dependable retinal imaging support everyday diagnostic practice.

Which end-use segment is growing the fastest in the nonmydriatic fundus cameras market?

Ophthalmic & optometrist offices are the fastest-growing end-use segment as retinal imaging becomes part of routine consultations, enabling earlier screening and more efficient in-office patient assessment.

Why is North America leading the nonmydriatic fundus cameras market?

North America leads with 39.64% share, driven by routine retinal imaging adoption, integrated diabetic retinopathy screening workflows, and strong access to advanced diagnostic equipment across clinical settings.

How is Asia Pacific driving fastest growth in this market?

Asia Pacific is growing at a 6.78% CAGR due to rising demand for high-volume, efficient eye screening and wider adoption of fast, non-dilated retinal imaging in resource-constrained care settings.

What are the prominent companies operating in the nonmydriatic fundus cameras landscape?

Major players in the nonmydriatic fundus cameras market include Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Canon Medical Systems Corporation (Japan), NIDEK Co., Ltd. (Japan), Kowa Company, Ltd. (Japan), Optomed Plc (Finland), Haag-Streit AG (Switzerland), Optos plc (United Kingdom).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →